Abstract CN103
Background
Constipation is a common symptom in cancer patients undergoing chemotherapy, radiotherapy or opioids. There are no validated and reliable scales to measure constipation as a side effect in Turkey. The aim of this study was to test the validity and reliability of the Turkish version of the Constipation Assessment Scale.
Methods
The study is methodological research. The sample included 100 cancer patients in the oncology department of a public hospital who agreed to participate in the study. Data were collected between 1 May and 1 September 2023. The validity and reliability of the scale were assessed in three stages: translation, validity (content and construct validity) and reliability. The scale was translated using the back translation technique. The content validity index was 1.00. The Cronbach's alpha coefficient was 0.93. The scale showed a significant difference between the lower and upper groups (p<0.05). The scale was translated using the back translation technique.
Results
The content validity index of the scale was determined as 1.00. Cronbach's alpha coefficient was 0.93. The scale showed a significant difference between the lower and upper groups (p<0.05). The scale made fine distinctions. It was observed that the intraclass correlation coefficient values regarding the agreement between test-retest measurements were high, and there was no difference between test-retest values (p<0.05). It was observed that the fit statistics calculated by confirmatory factor analysis were in acceptable compliance with the predetermined factor structure of the scale. Standardized coefficients show that factor loadings are high. Standard errors were low and t values were significant.
Conclusions
The study concludes that the scale is appropriate for the Turkish population and will be a useful tool for professionals, researchers, and health professionals in future studies.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
CN58 - Canadian resources and strategies to build global oncology nursing excellence
Presenter: Gayatre Maharaj
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN62 - Trends, clinicopathological features, surgical treatment patterns and prognoses of early-onset versus late-onset gastric cancer: A retrospective cohort study on 18877 patients
Presenter: Yingxue Liu
Session: EONS Poster Display session
Resources:
Abstract
CN63 - Quality of life among parents of children with cancer
Presenter: Abeer Hussain
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN74 - Exploring the correlation between spiritual health, quality of survival, and meaning of life among breast cancer chemotherapy patients
Presenter: Fang Zhao
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN75 - Telehealth interventions and functional outcomes in breast cancer rehabilitation: A systematic review
Presenter: Marco Invernizzi
Session: EONS Poster Display session
Resources:
Abstract
CN76 - A study of sexual dysfunction in Moroccan female survivors of gynaecological cancer: A prospective study about 220 patients
Presenter: Chadia Ezzouitina
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN77 - ‘Eating with others’: Planning, developing and testing a self-management intervention to promote social eating for patients living with and beyond head and neck cancer
Presenter: Mark Dornan
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN79 - Quality-of-Life (QoL) data published by clinical trials supporting drug approvals for renal cell carcinoma (RCC)
Presenter: Rowanne Seadon
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN80 - Why do some patients undergoing laryngectomy for head and neck cancer opt to not reacquire their voice?
Presenter: Miyoko Iwai
Session: EONS Poster Display session
Resources:
Abstract
Slides
CN81 - How to use a theoretical framework to inform intervention development in a breast cancer study?
Presenter: Sek Ying Chair
Session: EONS Poster Display session
Resources:
Abstract
Slides